Da-Ae Back

发表

Quality characteristics and antioxidant activity of onion peel extracts by extraction methods

K. Youn, Da-Som Jeong, Da-Ae Back, 2015 .

Clinical Pharmacokinetics of Oral Contraceptive Steroids

A. Breckenridge, D. Back, D J Back, 1983, Clinical pharmacokinetics.

Theophylline metabolism in human liver microsomes: inhibition studies.

D. Back, J. Tjia, J. Colbert, 1996, The Journal of pharmacology and experimental therapeutics.

Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation.

B. K. Park, E. Tomlinson, D. Back, 1996, The Journal of pharmacology and experimental therapeutics.

Effect of tuberculosis therapy on nevirapine trough plasma concentrations.

D. Back, A. de Ruiter, G. Dean, 1999, AIDS.

Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro.

D. Back, J. Tjia, P. Stevenson, 1989, British journal of clinical pharmacology.

Pharmacokinetics and protein binding of 3-ketodesogestrel and gestodene in the serum of women during 6 cycles of treatment with two low dose oral contraceptives

D. Back, E. Daume, A. Neiss, 1993, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

The lack of interaction between temafloxacin and combined oral contraceptive steroids.

D. Back, M. Orme, T. Mant, 1991, Contraception.

The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrel.

D. Back, S. Ward, S. Ward, 1991, Contraception.

Plasma concentrations of 3-keto-desogestrel after oral administration of desogestrel and intravenous administration of 3-keto-desogestrel.

D. Back, M. Orme, S. Grimmer, 1987, Contraception.

The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy.

A. Breckenridge, E. Perucca, M. J. Hall, 1980, Contraception.

Metabolism of the contraceptive steroid desogestrel by human liver in vitro.

D. Back, M. Orme, S. Madden, 1990, Journal of steroid biochemistry.

The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women.

A. Breckenridge, D. Back, M. Maciver, 1980, Contraception.

The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.

T. Shimada, C. Verhoeven, Da-Ae Back, 1998, The Journal of pharmacology and experimental therapeutics.

The effect of rifampicin on norethisterone pharmacokinetics

B. K. Park, D. Back, M. Maciver, 1979, European Journal of Clinical Pharmacology.